Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Payables (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Payables readings, the most recent being $302188.0 for Q1 2026.

  • On a quarterly basis, Payables rose 95.63% to $302188.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $302188.0, a 95.63% increase, with the full-year FY2025 number at $109525.0, down 33.96% from a year prior.
  • Payables reached $302188.0 in Q1 2026 per CBIH's latest filing, up from $159217.0 in the prior quarter.
  • The five-year high for Payables was $364788.0 in Q4 2023, with the low at $107660.0 in Q3 2025.
  • A 4-year average of $206973.3 and a median of $168355.0 in 2024 define the central range for Payables.
  • Year-over-year, Payables plummeted 56.75% in 2025 and then skyrocketed 95.63% in 2026.
  • Year by year, Payables stood at $364788.0 in 2023, then tumbled by 53.85% to $168355.0 in 2024, then decreased by 5.43% to $159217.0 in 2025, then surged by 89.8% to $302188.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Payables are $302188.0 (Q1 2026), $159217.0 (Q4 2025), and $107660.0 (Q3 2025).